What’s Next for Melanoma Immunotherapy?

In this revelatory and engaging presentation from 2014, Robert Vonderheide, MD, Phil, the Hanna Wise Professor in Cancer Research at Penn Medicine, discusses the immediate future for melanoma therapy. A leading researcher in cancer immunotherapy, Dr. Vonderheide reviews the spectrum of new and developing therapies for melanoma, including targeted CAR­-modified T cell therapy, the reappearance of vaccine therapy, and combination treatments, including hypofractionated radiotherapy and immunotherapy.



Related Links


May 12, 2016

Created by

Penn Physician VideoLink